Jiangsu Nhwa Pharmaceutical Co., Ltd.
002262
Classement en actions
#4603
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Prix de l'action
$3.28
Capitalisation boursière
$3.32B
Changement (1 jour)
4.19%
Changement (1 an)
-10.41%
Pays
CN
Échange Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Catégorie
Healthcare
Bénéfices pour Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Bénéfices en Jun 2026 TTM : $178.32M
Selon les derniers rapports financiers de Jiangsu Nhwa Pharmaceutical Co., Ltd., les bénéfices actuels de l'entreprise sont de $178.32M. En 2023, l'entreprise a réalisé un bénéfice de $165.10M, une augmentation par rapport à celui de 2022 qui était de $143.51M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Jiangsu Nhwa Pharmaceutical Co., Ltd. de 2005 à 2026
Bénéfices à la fin de chaque année
| Année | Bénéfices | Changez |
|---|---|---|
| 2026 (TTM) | $178.32M | 0.37% |
| 2024 | $177.65M | 7.60% |
| 2023 | $165.10M | 15.04% |
| 2022 | $143.51M | -0.40% |
| 2021 | $144.08M | 10.67% |
| 2020 | $130.19M | 18.18% |
| 2019 | $110.16M | 24.59% |
| 2018 | $88.42M | 29.21% |
| 2017 | $68.43M | 32.53% |
| 2016 | $51.63M | 11.41% |
| 2015 | $46.35M | 10.03% |
| 2014 | $42.12M | 24.43% |
| 2013 | $33.85M | 27.40% |
| 2012 | $26.57M | 38.55% |
| 2011 | $19.18M | 40.39% |
| 2010 | $13.66M | 48.52% |
| 2009 | $9.20M | 26.55% |
| 2008 | $7.27M | 35.65% |
| 2007 | $5.36M | 134.21% |
| 2006 | $2.29M | 10.87% |
| 2005 | $2.06M | 0.00% |
Bénéfices des entreprises similaires ou concurrentes
| Entreprise | Bénéfices | Différence de bénéfices | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 889.56% |
IN
|
